« Back
Home /
Partner: BioSentinel | Hölzel Diagnostika

BioSentinel

BioSentinel, Inc. is a leader in developing innovative tools and reagents for the study of botulinum neurotoxin (BoNT). They provide tests and assays that set new standards for speed, sensitivity, and accuracy while lowering testing costs and eliminating the use of animals.

BioSentinel's assays can detect BoNT in hours, with sensitivities that rival the "gold standard" mouse bioassay. Their assays are easy to use, adaptable to various applications, and can replace the laborious mouse bioassay with the cell-based assay. Since 2007, BioSentinel's laboratory has been at the forefront of technology advancements for improved BoNT research and detection.

They offer a suite of assays for detection and quantification of BoNT in various samples, such as food, serum, purified toxin, and drug product samples. The company has the expertise to match researchers with the right product to further their research.

BioSentinel's proprietary rapid detection technology is designed to meet the requirements of the US Department of Defense and the Department of Homeland Security to protect the nation from intentional misuse of these Class A bioterrorism agents. The company's technology also addresses the needs of pharmaceutical companies that sell botulinum neurotoxin for FDA-approved cosmetic and therapeutic applications.

The company has a vigorous research and development program, including a state-of-the-art laboratory in Madison, WI, and partners throughout the US and worldwide. BioSentinel maintains active collaborations with the National Wildlife Health Center, the US Army Medical Research Institute of Chemical Defense (Aberdeen Proving Grounds, MD), and the University of Wisconsin-Madison. Additionally, they are partnered with private companies who share BioSentinel's goals of developing innovative technologies/platforms for the detection, characterization, and quantification of BoNTs.

BioSentinel's team is uniquely qualified to design BoNT detection technologies for both biodefense programs and pharmaceutical uses and applications. Their team includes experts in the field with extensive experience and knowledge.